ESCI期刊Molecular Imaging and Radionuclide Therapy 2024/2025影响因子:0.923 (MOL IMAGING RADIONUC) (2146-1414). (RADIOLOGY, NU

显示全部楼层 · 发表于 2025-3-25 11:56:25

Submitted on: 02 March 2020. Revised on: 10 March 2020. Accepted on: 17 March 2020. Molecular Imaging and Radionuclide Therapy

显示全部楼层 · 发表于 2025-3-25 19:51:37

显示全部楼层 · 发表于 2025-3-25 23:25:38

Submitted on: 30 January 2010. Revised on: 09 February 2010. Accepted on: 19 February 2010. Molecular Imaging and Radionuclide Therapy

显示全部楼层 · 发表于 2025-3-26 00:45:17

Submitted on: 19 September 2019. Revised on: 22 October 2019. Accepted on: 17 November 2019. Molecular Imaging and Radionuclide Therapy

显示全部楼层 · 发表于 2025-3-26 05:19:07

Submitted on: 25 April 2020. Revised on: 19 May 2020. Accepted on: 15 June 2020. Molecular Imaging and Radionuclide Therapy

显示全部楼层 · 发表于 2025-3-26 10:16:48

Submitted on: 17 January 2019. Revised on: 26 February 2019. Accepted on: 17 March 2019. Molecular Imaging and Radionuclide Therapy

显示全部楼层 · 发表于 2025-3-26 13:58:42

Submitted on: 26 May 2011. Revised on: 15 June 2011. Accepted on: 06 July 2011. Molecular Imaging and Radionuclide Therapy

显示全部楼层 · 发表于 2025-3-26 17:13:38

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 13:56
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved